AKT1 and breast cancer: Estrogen deprivation induces synthetic lethality in ER+ breast cancer cells treated with a PI3K inhibitor or transfected with p110 siRNA [13], suggesting compensatory crosstalk between ER and PI3K/AKT signaling.